Author: Ken Dropiewski

Vensana Capital Closes $425 Million Fund III to Back Breakthrough Medical Technology Companies

MINNEAPOLIS & WASHINGTON–(BUSINESS WIRE)–Vensana Capital today announced the closing of Vensana Capital III with $425 million in committed capital. The fund was oversubscribed at its hard cap with the support of the firm’s existing limited partners alongside select new institutional investors, and it brings Vensana’s total capital under management to […]

SpectraWAVE Appoints Brad Davis as Chief Commercial Officer and Bill Kelly as Chief Financial Officer

BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today announced the addition of two seasoned executives to its leadership team. Brad Davis has been named Chief Commercial Officer (CCO), and Bill Kelly has been named Chief […]

Qure.ai appoints USA based Chief Commercial Officer to further global expansion strategy

New York, January 9, 2025: The world’s most adopted healthcare AI company, Qure.ai, has appointed a new Chief Commercial Officer to oversee and expand global sales and business development strategy. Based in New York, Jim Mercadante joins a growing commercial and operations team to consolidate growing momentum and orchestrate further […]

Christina Rodriguez, M.D., Named Medical Director of Advanced Cardiac Imaging at MemorialCare Heart & Vascular Institute at Long Beach Medical Center

LONG BEACH, Calif., Jan. 9, 2025 /PRNewswire/ — Christina Rodriguez, M.D., has been named medical director of advanced cardiac imaging at MemorialCare Heart & Vascular Institute at Long Beach Medical Center. Dr. Rodriguez is a fellowship-trained, board-certified, non-invasive…

Argon Medical Announces First Patient Enrollment in CLEAN-PE, a Prospective, Multicenter Study of a New Treatment for Pulmonary Embolism

PLANO, Texas, Jan. 9, 2025 /PRNewswire/ — Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the first patient enrollment in the CLEAN-PE study. The prospective,…

Peerbridge Health Unveils COR-INSIGHT Trial to Validate Revolutionary AI-Enabled Cardiac and Cardiopulmonary Diagnostics & Monitoring

Inexpensive wearable technology for diagnostics and monitoring has the power to transform cardiac care BRENTWOOD, Tenn., Jan. 9, 2025 /PRNewswire/ — Peerbridge Health has announced the launch of its landmark COR-INSIGHT Trial, which will validate the screening and diagnostic capabilities…

NorthStar Medical Radioisotopes and YAP Therapeutics Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Products

orthStar to support the development of YAP Therapeutics’ innovative radiolabeled products This collaboration merges the expertise and resources from both companies, including NorthStar’s state-of-the-art facilities The agreement guarantees that YAP Therapeutics will receive clinical trial-ready doses of its novel products in development January 08, 2025 08:01 AM Eastern Standard Time […]

CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson® Artificial Heart and Anticipates Continued Strong Momentum in 2025

Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024. 2024 Sales of €7 million (a 2.5-fold increase vs 2023). Cash burn reduced by over 20% vs 2023. 50 hospitals trained in Aeson® implants internationally1. Successful first “Aeson® User Meeting” and […]